The board of directors of Fagron NV has, following the advice of the nomination and remuneration committee, decided to co-opt Ms. Karin de Jong as executive director of Fagron. Karin de Jong will replace Mr. Jan Peeters who stepped-down as executive director of Fagron during the annual shareholders meeting of 9 May 2016. Karin de Jong is CFO of Fagron since May 2016. Fagron`s board of directors has taken notice of the resignation of Mr. Filiep Balcaen and Ms. Freya Loncin (permanent representative of Aubisque BVBA) as non-executive directors of Fagron. In accordance with article 15 of Fagron`s articles of association, the remaining directors decided to co-opt Mr. Marc Janssens and Mr. Marc Coucke (permanent representative of Alychlo NV) with immediate effect as new non-executive directors of Fagron. The formal appointment of Ms. De Jong, Mr. Janssens and Mr. Coucke will be proposed to the next general shareholders meeting of Fagron. Marc Janssens is director asset management and member of the executive committee of Baltisse since 2015. Marc Coucke is the founder of Omega Pharma. Following the sale thereof, he invests through NV Alychlo, in which he serves as chairman, in several listed and non-listed companies.